ADXN - Addex Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

784.9M

Cash

1.628M

Avg Qtr Burn

-1.957M

Short % of Float

0.01%

Insider Ownership

0.00%

Institutional Own.

3.41%

Qtr Updated

03/31/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
ADX71149 (JNJ-40411813) (mGlu2 PAM) Details Epilepsy	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Dipraglurant (mGlu5 NAM) Details Levodopa-induced dyskinesia associated with Parkinson’s disease	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Dipraglurant (mGlu5 NAM) Details Dystonia (Blepharospasm)	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.